SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) /
The cash flow of SCINAI IMMUNOTHERAPEUTICS LTD. over the past 5 years
Chart SCINAI IMMUNOTHERAPEUTICS LTD.: operating cash flow, capital expenditures, free cash flow, fiscal 2021–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, SCINAI IMMUNOTHERAPEUTICS LTD.'s operating cash flow was -$6.03M and its capital expenditures $24K, leaving free cash flow of -$6.05M. Free cash flow was below zero in all 5 years shown. It ranged from -$10.02M in fiscal 2023 to -$6.05M in fiscal 2025. Capital expenditures were highest in fiscal 2022, at $836K.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$6.03M | $24K | -$6.05M |
| 2024ended Dec 31, 2024 | -$6.33M | $12K | -$6.35M |
| 2023ended Dec 31, 2023 | -$9.38M | $637K | -$10.02M |
| 2022ended Dec 31, 2022 | -$7.26M | $836K | -$8.1M |
| 2021ended Dec 31, 2021 | -$7.43M | $139K | -$7.57M |
Fiscal years as SCINAI IMMUNOTHERAPEUTICS LTD. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on SCINAI IMMUNOTHERAPEUTICS LTD.
- The profitability of SCINAI IMMUNOTHERAPEUTICS LTD.
- The debt of SCINAI IMMUNOTHERAPEUTICS LTD.
- All of SCINAI IMMUNOTHERAPEUTICS LTD.'s financials, charted
Companies of a similar size
- PIIMPINJ, INC.
- NXSTNEXSTAR MEDIA GROUP, INC.
- HASIHA SUSTAINABLE INFRASTRUCTURE CAPITAL, INC.
- PSMTPriceSmart, Inc.
- AXAxos Financial, Inc.
Not investment advice. This page shows what SCINAI IMMUNOTHERAPEUTICS LTD. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.